1 Department of Radiology, Magee-Womens Hospital of UPMC, University of Pittsburgh School of Medicine, 300 Halket St, Pittsburgh, PA 15213.
2 Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
AJR Am J Roentgenol. 2015 Aug;205(2):448-55. doi: 10.2214/AJR.14.13448.
The objective of our study was to compare quantitative maximum breast mass stiffness on shear-wave elastography (SWE) with histopathologic outcome.
From September 2008 through September 2010, at 16 centers in the United States and Europe, 1647 women with a sonographically visible breast mass consented to undergo quantitative SWE in this prospective protocol; 1562 masses in 1562 women had an acceptable reference standard. The quantitative maximum stiffness (termed "Emax") on three acquisitions was recorded for each mass with the range set from 0 (very soft) to 180 kPa (very stiff). The median Emax and interquartile ranges (IQRs) were determined as a function of histopathologic diagnosis and were compared using the Mann-Whitney U test. We considered the impact of mass size on maximum stiffness by performing the same comparisons for masses 9 mm or smaller and those larger than 9 mm in diameter.
The median patient age was 50 years (mean, 51.8 years; SD, 14.5 years; range, 21-94 years), and the median lesion diameter was 12 mm (mean, 14 mm; SD, 7.9 mm; range, 1-53 mm). The median Emax of the 1562 masses (32.1% malignant) was 71 kPa (mean, 90 kPa; SD, 65 kPa; IQR, 31-170 kPa). Of 502 malignancies, 23 (4.6%) ductal carcinoma in situ (DCIS) masses had a median Emax of 126 kPa (IQR, 71-180 kPa) and were less stiff than 468 invasive carcinomas (median Emax, 180 kPa [IQR, 138-180 kPa]; p = 0.002). Benign lesions were much softer than malignancies (median Emax, 43 kPa [IQR, 24-83 kPa] vs 180 kPa [IQR, 129-180 kPa]; p < 0.0001). Usual benign lesions were soft, including 62 cases of fibrocystic change (median Emax, 32 kPa; IQR, 24-94 kPa), 51 cases of fibrosis (median Emax, 36 kPa; IQR, 22-102 kPa), and 301 fibroadenomas (median Emax, 45 kPa; IQR, 30-79 kPa). Eight lipomas (median Emax, 14 kPa; IQR, 8-15 kPa), 154 cysts (median Emax, 29 kPa; IQR, 10-58 kPa), and seven lymph nodes (median Emax, 17 kPa; IQR, 9-40 kPa) were softer than usual benign lesions (p < 0.0001 for lipomas and cysts; p = 0.007 for lymph nodes). Risk lesions were slightly stiffer than usual benign lesions (p = 0.002) but tended to be softer than DCIS (p = 0.14). Fat necrosis and abscesses were relatively stiff. Conclusions were similar for both small and large masses.
Despite overlap in Emax values, maximum stiffness measured by SWE is a highly effective predictor of the histopathologic severity of sonographically depicted breast masses.
本研究旨在比较剪切波弹性成像(SWE)定量最大乳腺肿块硬度与组织病理学结果。
2008 年 9 月至 2010 年 9 月,在美国和欧洲的 16 个中心,1647 名经超声可见乳腺肿块的女性同意参与该前瞻性方案进行定量 SWE;1562 名女性的 1562 个肿块有可接受的参考标准。记录每个肿块的三次采集的最大硬度定量值(称为“Emax”),范围从 0(非常软)到 180kPa(非常硬)。根据组织病理学诊断确定中位数 Emax 和四分位间距(IQR),并使用 Mann-Whitney U 检验进行比较。我们通过对直径为 9mm 或更小和大于 9mm 的肿块进行相同的比较,考虑了肿块大小对最大硬度的影响。
患者年龄中位数为 50 岁(均值为 51.8 岁;标准差为 14.5 岁;范围为 21-94 岁),病变直径中位数为 12mm(均值为 14mm;标准差为 7.9mm;范围为 1-53mm)。1562 个肿块(32.1%为恶性)的中位数 Emax 为 71kPa(均值为 90kPa;标准差为 65kPa;IQR 为 31-170kPa)。在 502 个恶性肿瘤中,23 个(4.6%)导管原位癌(DCIS)肿块的中位数 Emax 为 126kPa(IQR,71-180kPa),比 468 个浸润性癌(中位数 Emax,180kPa [IQR,138-180kPa])软(p = 0.002)。良性病变比恶性肿瘤软得多(中位数 Emax,43kPa [IQR,24-83kPa] 比 180kPa [IQR,129-180kPa];p < 0.0001)。常见的良性病变是柔软的,包括 62 例纤维囊性改变(中位数 Emax,32kPa;IQR,24-94kPa)、51 例纤维化(中位数 Emax,36kPa;IQR,22-102kPa)和 301 例纤维腺瘤(中位数 Emax,45kPa;IQR,30-79kPa)。8 个脂肪瘤(中位数 Emax,14kPa;IQR,8-15kPa)、154 个囊肿(中位数 Emax,29kPa;IQR,10-58kPa)和 7 个淋巴结(中位数 Emax,17kPa;IQR,9-40kPa)比常见的良性病变软(脂肪瘤和囊肿的 p<0.0001;淋巴结的 p=0.007)。风险病变比常见的良性病变稍硬(p=0.002),但倾向于比 DCIS 软(p=0.14)。脂肪坏死和脓肿相对较硬。对于小肿块和大肿块,得出的结论相似。
尽管 Emax 值存在重叠,但 SWE 测量的最大硬度是超声描绘的乳腺肿块组织病理学严重程度的有效预测指标。